Why partner with us?

  • UT Health Physicians have over 100 specialties and subspecialties with 1.6 million patient visits per year at 16 clinics.

  • The Mays Cancer Center is home to the world-renowned Institute for Drug Development (IDD) where many of the most commonly used FDA-approved anticancer drugs were developed. At any given time, the IDD is testing as many as 60 new drugs and drug combinations and has over 180 clinical trials open for patient enrollment.

  • UT Dentistry offers 9 specialty clinics staffed by more than 100 faculty experts.

  • For over a decade, the Association for the Accreditation of Human Research Protection Programs (AAHRPP) has recognized the ethical and efficient operations of our clinical research program.

  • As a Clinical and Translational Science Award (CTSA) hub, we emphasize the importance of accelerating the research process to translate scientific discovery and offer a master IRB reliance agreement through a SMART IRB platform expediting the regulatory approval process for multisite studies.

  • San Antonio is the largest minority-majority city in the United States and is home to 7 military installations comprising a large active-duty and retired military population with unique needs.

  • Through multi-modal strategies, we aim to bring more awareness to our communities about their role in clinical trials.

Contact Us

Clinical Trials Office (CTO)
Jason Bates, MBA

210-562-6818

vprcto@uthscsa.edu

Mays Cancer Center Clinical Trials Office
Cindy McKeown, RN, BSN, MPA

210-450-1286

ctofinance@uthscsa.edu

$6,638,575

industry clinical trial revenue in 2020

Over 170

actively recruiting cancer trials

20

institutes and centers with diverse research specialties

Innovation Highlight

Dr. Barbara Taylor is leading a COVID-19 research team conducting a clinical trial evaluating an investigational vaccine to see if it helps prevent COVID-19.

Advancing Commercialization

º£½ÇÂ×ÂÒ researchers are collaborating with a team from The University of Texas at Austin to build a new type of ventilator made of inexpensive, widely available materials to help fill the demand created by the spread of COVID-19 for these critical devices that help patients breathe.

Robert J. Chilton, D.O.

“º£½ÇÂ×ÂÒ cardiologists have led pinnacle studies that changed the standard of care for patients. Findings from the multi-site study, COURAGE, remain the gold standard treatment used for patients, worldwide. Our team is proud to lead trials at the South Texas Veteran’s Audie Murphy Hospital, a proven national leader in patient recruitment and retention.â€

Robert J. Chilton, D.O., associate professor of medicine and director of the Cardiac Catheterization Laboratory at the Audie L. Murphy Memorial Veterans' Hospital

Spotlight